First Genetic Disease Identification Centre Launched In Kerala

by Shirley Johanna on  January 4, 2016 at 4:25 PM Hospital News   - G J E 4
Kerala Institute of Medical Sciences (KIMS) Hospital in collaboration with MedGenome has launched the first genetic disease identification center.
First Genetic Disease Identification Centre Launched In Kerala
First Genetic Disease Identification Centre Launched In Kerala

M. I. Sahadulla, chairman, KIMS Healthcare Group said their mission was to help patients and families with various genetic conditions through expert counseling and state of the art genetic testing facilities in complete confidentiality.

‘The genetic disease identification center will identify patients with the risk of a genetic condition provide them information on genetic testing and treatment.’
This new collaboration envisages genetic counseling and testing for rare and common genetic, hereditary diseases that includes various types of cancers, cardiovascular, neurological and gastro-intestinal diseases, said Sahadulla.

In the first phase of the collaboration, the specialists at KIMS hospital will help identify patients at possible risk of a genetic condition and refer them to counselor who are specialized in gathering and analyzing family history and inheritance patterns of the disease.

They will provide information about genetic testing and related procedures for further investigations and treatment.

In the second phase, statistical incidence, data collection and community based studies will be initiated.

"MedGenome will also partner with the clinicians in gaining underlying genetics insights into several human diseases and thereby address the pressing health problems of the common man," said Girish Mehta, CEO, MedGenome, India.

Today congenital and hereditary genetic diseases are becoming a significant health burden in India, and hence there is a need for adequate and effective genetic testing and counseling services and in Kerala this new partnership is certainly going to help such patients.

Source: IANS

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
Notify me when reply is posted I agree to the terms and conditions

You May Also Like